MyFinsight
Home
Blog
About
Contact
Download
Download image
Unrealized gain on
marketable securities
$285K
Total comprehensive
loss
-$86,740K
Total other
comprehensive gain (loss)
$231K
Reclassification of net gains
included in net loss
$54K
Net loss
-$86,971K
Interest and other
income, net
$11,084K
Loss from operations
-$98,055K
Total operating
expenses
$98,055K
Research and development
$79,159K
General and
administrative
$18,896K
Back
Back
Income Statement
source: myfinsight.com
MBX Biosciences, Inc. (MBX)
MBX Biosciences, Inc. (MBX)